Clinical Trials Directory

Trials / Completed

CompletedNCT03410511

Propylene Glycol/Glycerol Intake and Cardiorespiratory Function

Reversibility of Propylene Glycol/Glycerol Intake Effects on Cardiorespiratory Function

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Université Libre de Bruxelles · Academic / Other
Sex
Male
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Propylene glycol/Glycerol intake is increasingly popular. The propylene glycol/glycerol intake effects on cardiorespiratory function are unknown.

Detailed description

Background. Propylene glycol/Glycerol intake is increasingly popular. The propylene glycol/glycerol intake effects on cardiorespiratory function are unknown. Weaning of propylene glycol/glycerol could allows a quick clearance of propylene glycol/glycerol from the body, with subsequent recovery of cardiorespiratory function. Specific aim of the research. This research proposal tests the following hypothesis regarding the reversibility of propylene glycol/glycerol and nicotine intake: * Propylene glycol/glycerol cessation restores cardiorespiratory function. * Chronic propylene glycol/glycerol and propylene glycol/glycerol/nicotine intake induces specific serum and urine proteomics profile, which are partially reversed after cessation. * Chronic propylene glycol/glycerol and propylene glycol/glycerol/nicotine intake induces specific serum and urine metabolomics profile, which are partially reversed after cessation.

Conditions

Interventions

TypeNameDescription
OTHERNicotine free intakeThe participant will wean off nicotine during five days before the experimental session. At the start of the experimental session, participants will be exposed to acute propylene glycol/glycerol (mix 50:50) intake.
OTHERNicotine intakeThe participant will pursuit his regular nicotinic propylene/glycerol intake five days before the experimental session. At the start of the experimental session, participants will be exposed to acute propylene glycol/glycerol (mix 50:50) intake.
OTHERCessation intakeThe participant will completely stop his regular nicotinic propylene/glycerol intake during five days before the session. At the start of the experimental session, participants will mimick intake with the device turns off.

Timeline

Start date
2018-01-15
Primary completion
2019-06-30
Completion
2020-06-30
First posted
2018-01-25
Last updated
2020-11-03

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03410511. Inclusion in this directory is not an endorsement.